The Cooper Companies, Inc. (NASDAQ:COO) Shares Bought by Alliance Wealth Advisors LLC UT

Alliance Wealth Advisors LLC UT raised its position in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 3.8% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 11,262 shares of the medical device company’s stock after buying an additional 416 shares during the period. Alliance Wealth Advisors LLC UT’s holdings in Cooper Companies were worth $1,035,000 at the end of the most recent quarter.

Several other institutional investors also recently bought and sold shares of the company. Fulton Bank N.A. raised its holdings in Cooper Companies by 3.0% during the fourth quarter. Fulton Bank N.A. now owns 3,718 shares of the medical device company’s stock worth $342,000 after purchasing an additional 109 shares in the last quarter. Mitchell & Pahl Private Wealth LLC lifted its holdings in shares of Cooper Companies by 1.5% in the 3rd quarter. Mitchell & Pahl Private Wealth LLC now owns 7,986 shares of the medical device company’s stock valued at $881,000 after buying an additional 117 shares during the period. Bleakley Financial Group LLC increased its holdings in shares of Cooper Companies by 2.1% in the 3rd quarter. Bleakley Financial Group LLC now owns 5,767 shares of the medical device company’s stock valued at $636,000 after purchasing an additional 119 shares in the last quarter. MassMutual Private Wealth & Trust FSB lifted its position in shares of Cooper Companies by 15.6% during the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 1,008 shares of the medical device company’s stock valued at $93,000 after acquiring an additional 136 shares during the period. Finally, Greenleaf Trust boosted its position in Cooper Companies by 5.0% during the fourth quarter. Greenleaf Trust now owns 2,915 shares of the medical device company’s stock worth $268,000 after purchasing an additional 139 shares in the last quarter. 24.39% of the stock is owned by institutional investors and hedge funds.

Cooper Companies Stock Down 1.3 %

COO stock opened at $95.34 on Tuesday. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.91 and a quick ratio of 1.12. The company has a 50-day moving average of $95.65 and a two-hundred day moving average of $99.74. The stock has a market capitalization of $19.03 billion, a price-to-earnings ratio of 48.89, a price-to-earnings-growth ratio of 2.45 and a beta of 0.99. The Cooper Companies, Inc. has a 52-week low of $84.76 and a 52-week high of $112.38.

Cooper Companies (NASDAQ:COO) last issued its quarterly earnings results on Thursday, December 5th. The medical device company reported $1.04 EPS for the quarter, topping the consensus estimate of $1.00 by $0.04. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. The company had revenue of $1.02 billion for the quarter, compared to the consensus estimate of $1.03 billion. During the same period in the previous year, the business posted $0.87 EPS. The company’s revenue for the quarter was up 9.8% on a year-over-year basis. As a group, equities research analysts anticipate that The Cooper Companies, Inc. will post 3.98 EPS for the current year.

Wall Street Analysts Forecast Growth

Several equities research analysts have issued reports on the stock. StockNews.com cut shares of Cooper Companies from a “buy” rating to a “hold” rating in a research note on Wednesday, December 11th. Needham & Company LLC restated a “hold” rating on shares of Cooper Companies in a report on Friday, December 6th. Wells Fargo & Company increased their target price on Cooper Companies from $115.00 to $118.00 and gave the company an “overweight” rating in a research note on Friday, December 6th. Morgan Stanley cut their price objective on shares of Cooper Companies from $104.00 to $102.00 and set an “equal weight” rating on the stock in a report on Friday, December 6th. Finally, Citigroup dropped their target price on shares of Cooper Companies from $116.00 to $115.00 and set a “buy” rating for the company in a research report on Friday, December 6th. Four equities research analysts have rated the stock with a hold rating and nine have issued a buy rating to the stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $117.00.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.